Back to search
FDAFDA · Food and drugs·Recall number D-1723-2019

Macrobid Urinary Tract Anitbacterial, 100 mg, 100-count bottle, Rx Only, Mfg. by: Norwich Pharmaceuticals, Inc. Norwich, NY 13815 USA Dist. by: Almatica Pharma, Inc. Pine Brook, NJ 07058 USA, NDC 52427-285-01

Published August 21, 2019 · Recall initiated: July 24, 2019

Summary

FDA records drug Class II recall D-1723-2019, published August 21, 2019 and initiated July 24, 2019. Recalling firm: Alvogen, Inc; Status: Terminated; Reported quantity: 4272 bottles; Lot: Lot # 472990, Exp 03/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if MACROBID has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MACROBID
Manufacturer
Alvogen, Inc
Distributor
Natonwide, PR
UPC
0352427285011
Lot
Lot # 472990, Exp 03/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Macrobid Urinary Tract Anitbacterial, 100 mg, 100-count bottle, Rx Only, Mfg. by: Norwich Pharmaceuticals, Inc. Norwich, NY 13815 USA Dist. by: Almatica Pharma, Inc. Pine Brook, NJ 07058 USA, NDC 52427-285-01 recalled?

Yes. FDA published recall D-1723-2019 on August 21, 2019. Reported hazard: Failed dissolution specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MACROBID. UPC: 0352427285011.